Commensal microorganisms influence a variety of host functions in the gut, including immune response, glucose homeostasis, metabolic pathways and oxidative stress, among others. This study describes how Salmonella Typhi, the pathogen responsible for typhoid fever, uses similar strategies to escape immune defense responses and survive within its human host. To elucidate the early mechanisms of typhoid fever, we performed studies using healthy human intestinal tissue samples and "mini-guts," organoids grown from intestinal tissue taken from biopsy specimens. We analyzed gene expression changes in human intestinal specimens and bacterial cells both separately and after colonization. Our results showed mechanistic strategies that S. Typhi uses to rearrange the cellular machinery of the host cytoskeleton to successfully invade the intestinal epithelium, promote polarized cytokine release and evade immune system activation by downregulating genes involved in antigen sampling and presentation during infection. This work adds novel information regarding S. Typhi infection pathogenesis in humans, by replicating work shown in traditional cell models, and providing new data that can be applied to future vaccine development strategies.
Introduction
Bacterial pathogens represent a significant global burden to human health resulting in chronic infection, significant mortality, certain cancers, and diminished quality of life [23, 38] . Salmonella enterica serovar Typhi (STY) is a human-restricted, gastrointestinal pathogen whose successful infection results in Typhoid fever or chronic infection [30] . Typhoid fever is frequently fatal when untreated in pediatric or immunocompromised populations [9, 31, 51, 79] . It affects an estimated 11.9 to 26.9 million people annually [6, 49, 50] , with estimated financial burdens equaling roughly a third of the gross national income for patients in undeveloped areas of Southeast Asia [35] . Current treatments depend on antibiotics; however, STY is rapidly developing antibiotic resistance, thereby increasing both the risk and severity of infection.
STY is a Gram-negative, enteric pathogen of the genus Salmonellae, species enterica, subspecies enterica. The subspecies enterica represents two serovars: Typhimurium and Typhi. Genetically related, but phenotypically divergent, S. Typhimurium (STM) can cause localized inflammation of the small intestine, diarrhea and cramping. Conversely, STY infection has an incubation period of up to two weeks and results in systemic bacteremia with limited or no gastrointestinal symptoms. Comparative genomics between the two serovars reveals 480 STM-unique genes and 600-STY-unique genes [66] ; notable STY genetic acquisitions include a capsule-encoding specific pathogenicity island (SPI) [78] , two human-like serine-threonine kinases [73] and a typhoid toxin [18, 21] . Numerous STY genes contain mutations relative to the STM homologs, with 0.6% of the STM genome encoding pseudogenes compared to 5% in the STY genome [66] .
Current STY vaccination strategies include products that are expensive to produce and store. The attenuated oral vaccine Ty21a, which requires several immunizations to create a sustained immune response, confers protection in 62-96% of vaccinated individuals [41] . Alternative vaccine candidates currently in phase I and phase II studies have been generated by targeting virulence genes related to acid resistance, stress response, osmolarity and invasion. These gene targets are combined with gene deletions resulting in limited intracellular replication [24] . In most STY vaccine candidates, deleted genes attenuate infection. A notable exception is the constitutive expression of the STY-specific [82] immune-capsule suppressing regulator [78] tviA gene [24] . Despite the development of several vaccine strains against STY, no strategy confers long-term protection in a cost-effective manner.
Vaccine development against typhoid fever is hindered by significant assumptions about how S. Typhi causes infection in its human host. Specifically, no data are available regarding STY interaction with the small intestinal mucosa as the first step in the cascade of events ultimately leading to infection. Moreover, there have been no studies evaluating bacterial gene expression and consequences on host gene expression that occur during these critical early moments of infection. Despite fundamental differences in the pathology of infected humans relative to infected mice, and significant genomic differences between the two serovars, our current understanding of STY infection is mainly derived from the STM mouse model. Moreover, the two-week incubation period between STY exposure and onset of disease symptoms demonstrates a critical window in which STY infection is active prior to the onset of clinical disease. In recent years, human-derived organoid systems [19, 64, 67, 80, 84] or three-dimensional cell line models [29, 60, 68, 69] have gained traction as a strategy to study hostpathogen interactions. These models have enabled new insight into cellular response during early STM infection to identify the role of bacterial genes n, such as the SPI-1 operon [60] , or STM manipulation of signaling cascades [84] ; however, few studies combining STY and human-derived organoid monolayers have been published.
Our work overcomes these shortfalls by placing STY bacteria directly onto human small intestinal tissue. In this study, we use an ex vivo, human intestinal tissue infection model and a human organoidderived monolayer model. Infected biopsies were analyzed for transcriptional changes, cytokine profiling and electron microscopy, with specific mechanisms explored using the organoid monolayer model. This work sought to detail critical early events in Typhoid fever development to understand pathogenic mechanisms in human-derived tissue with the goal of identifying novel targets for vaccine development.
Materials and Methods

Bacterial Strains, Growth Conditions and Biopsy Infection
For all experiments, Salmonella enterica serovar Typhi strain Ty2 (STY, ATCC® Number: 700931) or serovar Typhimurium strain SL1344 (STM) (kind gift of Bobby Cherayil, Massachusetts General Hospital, Boston MA) were re-streaked bi-monthly on LB-agar plates. For experiments conducted under traditional laboratory conditions, an overnight culture from a single colony of STY or STM was prepared in Miller formula LB-broth (Sigma, St. Louis, MO) at 37°C with shaking at 225 rpm. The next day, overnight cultures were diluted 1:50 into secondary subcultures and grown to log phase. To prepare the bacteria grown under pro-invasion conditions, a day culture in Miller formula LB broth from a single colony of STY or STM was started at 37°C without shaking. After 4-8 h growth, a secondary culture diluted 1:50 in Miller LB was prepared and grown overnight at 37°C without shaking. Bacteria were normalized to an OD600 of 0.5 prior to experimentation, pelleted by centrifugation and resuspended in warm Dulbecco's Modified Eagle Medium (DMEM) (Gibco, Grand Island, NY) for use in infection. All biopsies were infected with 1 × 10 8 bacteria in 250 μL DMEM for a maximum of 2 h. Biopsies were mounted using a snapwell system (Corning, Corning NY) with orientation confirmed by a dissecting microscope. Mounted biopsies acclimated for 30 m prior to removal of media and replacement with control DMEM or DMEM containing STY or SL1344. After 2 h of infection, apical and basolateral medium and biopsies were collected. For gentamicin protection assays, after 2 h infection the apical surface was washed 3× in phosphate buffered saline (PBS), and DMEM containing 5μg/mL gentamicin (Gibco) was added for 30 m at 37°C. Afterward, biopsies were washed in PBS (Gibco) and subsequently homogenized in 0.5% Triton-X (Sigma) in PBS for serial dilution plating to determine CFU/mL recovery.
Isolation and Generation of Human Organoids; Preparation of Organoid-derived Epithelial Monolayers
The isolation and generation of human organoids was adapted from the protocol published by VanDussen et al. [76] . Briefly, human terminal ileum biopsies were processed in dithiothreitol (DTT) and ethylenediaminetetraacetic acid (EDTA) in PBS with penicillin/streptomycin (P/S, Gibco) to isolate the crypt fractions. This process was repeated 4-5 times; the fractions with the greatest number of crypts were pooled and resuspended in Matrigel (Corning, NY). Spheres were maintained in culture in 1:1 LWRN-conditioned medium and Intestinal Stem Cell (ISC) medium supplemented with Y-27632 (Sigma or Calbiochem, La Jolla, CA) and A-8301 (Sigma or Tocris, Minneapolis, MN). Spheres were fed every 2-3 days and split prior to differentiation. Undifferentiated cells were seeded onto transwell inserts and maintained in culture until monolayers formed. 48 h prior to experiment, monolayers were treated with apical N-[2S-(3,5-difluorophenyl)acetyl]-L-alanyl-2-phenyl-1,1-dimethylethyl ester-glycine (DAPT) (Calbiochem) to induce differentiation. Monolayers were assessed by quantitative reverse transcriptase polymerase chain reaction (qPCR) and confocal microscopy to identify markers for differentiated epithelial cells, as well as, Trans epithelial electrical resistance (TEER) and fluorescein isothiocyanate (FITC) dextran to determine barrier integrity.
Human Donors
All protocols for recruitment of human subjects and use of human terminal ileum biopsies were approved by Massachusetts General Hospital / Partners Healthcare IRB (Protocol 2014P002001). Prospective donors without chronic medical conditions who were scheduled to undergo a diagnostic colonoscopy were screened for good general health. Exclusion criteria included pregnancy, a known diagnosis of an autoimmune disorder or any chronic medical condition that would increase the risk from a gastrointestinal biopsy, and an inability or unwillingness to provide written informed consent. Donors signing informed consent contributed four to eight biopsies that were transported to the laboratory and used immediately to maximize tissue viability.
RNA Isolation and Transcriptomic Analysis
Following treatment (mock or infection) biopsies were immediately snap frozen on dry ice and stored at −80 until use. The control biopsy group contains four samples, the infected biopsy group contains five samples and the bacteria control group contains four samples. Biopsy ribonucleic acid (RNA) was isolated in Trizol (Ambion, Carlsbad CA), using the Direct-Zol isolation kit (Zymo, Irvine, CA) following manufacturer's instructions. RNA from purified bacterial cultures was isolated using the RNAeasy kit (Qiagen, Waltham, MA) following manufacturer's instructions. Purified RNA was submitted to GENEWIZ (Frederick, MD) for RNA-sequencing, bacterial rRNA and human rRNA depletion, RNA library preparation (multiplexing and cluster generation) and sequencing on a 1x50bp SR, HiSeq 2500; rapid run flow cells were conducted by GENEWIZ. The reads generated for each RNA sample were analyzed using an Ergatis-based RNA-Seq analysis pipeline [59] . Quality control of the sequences was performed using FastQC (version 0.10.0) [3] . Human sequencing reads were aligned to the Homo sapiens reference genome GRCh38.78 using TopHat (version 2.1.1) [34] . Bacterial reads were aligned to Salmonella enterica serovar Typhi strain Ty2 genome (NCBI Reference Sequence: NC_004631.1) using Bowtie (version 0.12.9) [40] . The number of reads that aligned to the predicted coding regions were determined using HTSeq (version 0.4.7) [5] . Differential gene expression was analyzed using DESeq (version 1.5.24) [4] Full data sets were uploaded to Ingenuity Pathway (licensed to W. Flavahan), and differentially expressed genes were used to identify the pathways changed in infected samples. To identify differentially expressed STY genes, read files were uploaded into KBASE [7] and analyzed as follows: Samples were assigned to control or experimental samples to define a sample set for downstream analysis. The reads were then aligned using Bowtie2 to create an RNAseq alignment set. Transcripts were then assembled using StringTie, and differential expression was identified using CuffDiff. Further analysis was conducted to create expression matrices, heatmaps or cluster analysis. Differentially expressed genes were uploaded into KEGG to map bacterial pathways. Data is accessible in GEO under accession GSE113333.
Cytokine Analysis
Multiplex cytokine profiling was conducted using a 13plex human pro-inflammatory profiling kit in a Mesoscale Discovery System platform (Meso Scale Diagnostics, Rockville MD). Apical and basolateral samples from infected and control biopsies were assayed per manufacturer's instructions. Results were calculated to determine total volume of cytokine released. Statistical significance was determined by one-way ANOVA with Tukey post-test and represent an n of 15 controls, 10 STM and 10 STY infected. *p ≤ 0.05, **p ≤ 0.005, ***p ≤ 0.0005.
Western Blot Analysis
Snap-frozen biopsies were thawed in RIPA buffer (Sigma) + 2× protease inhibitors (Roche, Burlington NC) + 2× phosphatase inhibitors (Roche) on ice. Biopsies were homogenized using biomasher II tubes (Kimble, Vineland NJ) and protein concentration was quantified by protein assay (Biorad, Hercules, CA). 10 μg of protein were run on a 4-20% protein gel (Biorad) and transferred onto membrane (Biorad). Membranes were blocked in 5% BSA for 30 m followed by overnight incubation in the following antibodies: mouse anti-β-tubulin (RRID:AB_ 2715541), rabbit anti-pP44/42 MAPK (RRID:AB_2315112), rabbit antip-SAPK/JNK (RRID:AB_823588), rabbit anti-pP38 (RRID:AB_2139682), rabbit anti-pP65 (RRID:AB_331284) (all Cell Signaling Technologies, Danvers, MA). Densitometry was calculated as: ((P-gene/area)/(Actin/ Area) experimental )/((P-gene/area)/(Actin/Area) Media Control )). Significance was calculated by paired, two-tailed t-test, *p ≤ 0.05.
Permeability and Cell Viability
Apical supernatants were assessed for lactate dehydrogenase (LDH) release using Promega Cytox Kit (Promega, Madison, WI) per manufacturer's instructions. To assess paracellular permeability, biopsies were monitored using a TEER apparatus (World Precision Instruments, Sarasota, FL). Alternatively, passage of 1μg/mL 4kD FITC Dextran was assessed by florescence in the basolateral medium using Biotek Synergy 2 and compared against serial dilutions of stock FITC dextran to generate a standard curve. No significance was determined by paired, two-tailed t-test.
Immunostaining and Microscopy Studies
For immunostaining, hematoxylin & eosin (H&E) and Periodic Acid Schiff (PAS) analysis, biopsies were fixed in 4% paraformaldehyde at room temperature for 30 m followed by storage in 70% ethanol until paraffin embedding. Sections were stained using the antibodies against the following proteins: mouse anti-Actin (RRID: AB_11004139, Invitrogen/Thermo-Fisher), rabbit anti-Zo1 (RRID: AB_2533938, Invitrogen), mouse anti-EPCaM (RRID:AB_10981962, Thermo Fisher, Waltham, MA), rabbit anti-rab5 (RRID:AB_823625, Cell Signaling Technologies), goat anti-Muc2 (RRID:AB_2146667, Santa Cruz Biotechnology, Dallas, TX), mouse anti-Salmonella (RRID:AB_1125358, BD Biosciences, San Jose, CA), rabbit-anti-Salmonella (RRID:AB_561201, Pierce/Thermo-Fisher), rabbit-anti-Salmonella-biotin conjugated (RRID:AB_1018415, Invitrogen/ThermoFisher) and mouse anti-tubulin (RRID:AB_2715541, Cell Signaling Technologies). Fluorescent, conjugated, secondary monoclonal antibodies were used for detection. For samples using streptavidinbiotin detection, avidin-biotin blocking was performed prior to staining (Life Technologies/Thermo-Fisher). Samples were imaged using a Nikon A1SiR confocal microscope.
For transmission electron microscopy (TEM) analysis, samples were fixed in 2%PFA/2.5% Glut in 0.1 M Sodium Cacodylate followed by mounting on grids and imaged using a transmission electron microscope (JEOL, Peabody, MA).
Results
Human Intestinal Biopsies Are Susceptible to STY Infection
STY colonize and invade the distal ileum of humans [20] . Terminal ileum biopsies obtained during clinically indicated colonoscopies were mounted in microsnapwell devices to allow polarized exposure to microorganisms from the luminal side [8] (see schematic in Fig. 1A and donor characteristics in Table 1 ). The biopsies were infected with 10 8 CFU of STY. The bacterial inoculum was prepared by growing STY under static conditions in LB-miller to maximize the expression of genes important in epithelial cell invasion [75] (Fig. 1B,C) . After 2 h, invasion and biopsy status was assessed by transmission electron microscopy (TEM), hematoxylin and eosin (H&E) staining for light microscopy, Periodic acid Schiff (PAS) staining for light microscopy and gentamicin protection assay. Intracellular bacteria were detected by TEM, H&E and gentamicin protection assay (Fig. 1D-F) . Microvilli destruction and epithelial cell disorganization were observed at sites of bacterial invasion (Fig. 1F, 4B ). No gross differences in H&E were observed (Fig. 1D) , while minor differences in mucus staining was observed after infection by PAS staining.
Downregulation of Genes Involved in the Host Immune Response Is Observed Through Transcriptomic Analysis
We performed RNA-sequencing to determine differentially expressed genes in both STY and host cells ( Fig. 2A , qPCR validation in Supplementary Fig. 1 ). Gene expression profiles from non-infected control biopsies and STY-infected biopsies were compared to determine significantly upregulated (p ≤ 0.05 and N2-fold induction) and downregulated (p ≤ 0.05 and b0.5-fold reduction) genes. Similar gene expression changes were observed across samples or control groups with some anticipated differences attributed to human-to-human variability (Fig. 2B ). For human-specific genes, very few genes were upregulated in response to infection (Table 2A) . Regulatory RNAs, the antioxidant GSTM1, zincinteracting protein CRIP1 and chemokine CCL25 were among the eight significantly upregulated genes in infected samples. Reducing stringency to include genes that satisfied our significance cutoff but which were expressed below our 2-fold cutoff, revealed the expression of mucin MUC5B, the cytoskeletal gene EPPK1 and several metabolism genes induced after infection. Conversely, 57 genes were significantly downregulated (Table 2B) . Ultimately, the transcriptional profile of downregulated genes demonstrated significant clustering in several pathways including B-cell receptor signaling, coordination between innate and adaptive immune response, cell signaling and other pathways (Fig. 2C ). This data set indicated that STY can hinder the activation of the mucosal immune response of the host during the first 2 h of invasion.
Invading STY Showed Differential Transcriptomic Profile Compared to Control Bacteria Related to Key Transcriptional and Invasive Pathways Important for Virulence
In general, pathogenic bacteria produce effector proteins that exploit host pathways to promote their survival. Therefore, we evaluated changes in bacterial gene expression occurring concurrently with the changes in host gene expression in the same tissue explants. Similar gene expression profiles were detected in control bacteria relative to the bacteria infecting the gut mucosa-with a single notable exception ( Fig. 2D ) -that was further emphasized during cluster analysis (Fig. 2E ). To identify patterns in gene expression, clusters of genes with similar expression patterns were generated using KBASE (Fig. 2E) , with the most significant groups showing similarity in gene expression changes for cluster 1: ribosome/metabolism genes; cluster 2: virulence genes and hypothetical proteins; and cluster 3: hypothetical proteins and unknown function. Surprisingly, the gene expression profile observed during STY infection (Fig. 2E , Table 3A and 3B) was remarkably different from what is predicted during STM infection (Fig. 2F) . STM requires SPI-1 [1, 32, 75, 85] , rpoS and ompR [24] expression, which was observed in our bacterial inoculum and cultures grown in DMEM, but downregulated in bacteria invading the human gut mucosa. STY upregulated genes included numerous ribosome genes and enzymes. Upregulated enzymes (T1853, T0310, T4519 and T3866) encode eukaryotic-like serine/threonine kinases, acetyltransferases and inositol monophosphatase (Table 3A) which may have implications in the modulation of host signaling. Multiple components of the general secretory pathway (secD, secF, secG, secY) were also upregulated ( Supplementary Fig. 1 ), suggesting that non-T3SS proteins are also utilized during infection. Several components of the SPI-2 operon including sseB, sseA, ssaG, ssaM, ssaR, ssaS and ssaO were downregulated relative to bacteria grown in DMEM alone (Table 3B , Supplementary Figs. 2, 2F ), indicating that our model is capturing early events during S. Typhi pathogenesis, as expression of SPI-2 occurs during intracellular growth for STM. Interestingly, the SPI-7 operon-encoded Vi antigen is expressed in our inoculum with several genes located within the SPI-7 operon upregulated during biopsy infection (tviD, tviE), consistent with previous reports generated by using bovine epithelial mucosa [62] .
Cytokine Release Is Uncoupled from Transcriptional Replenishment and Mediated by Blocked MAPK and NF-kB Signaling Pathways
During clinical progression of typhoid fever [11, 47, 56, 63, 70] , limited gastrointestinal symptoms are reported suggesting that STY invades with limited immune activation [82] . Using supernatants from infected biopsies, cytokine release was assayed using a multiplex ELISA method. Compared to control biopsies, infected biopsies demonstrated differential cytokine production both directionally (apically and basolaterally) and in response to infection with either STM or STY. The cytokine release profile was predominantly apical for STY and bidirectional for STM. For most cytokines, STM trigged a robust and uniform cytokine release, while STY infection led to mild cytokine release (e.g., IL-10, IL-2, IL-4) (Fig. 3A) . Only half of the biopsies assayed secreted IL-13, IL-10, IL-4 and IL-2 in response to infection. The cytokine release profile for IFN-γ, IL-8, IL-1β and TNFα was more uniform across all donors. As much of the STY-induced cytokine release profile is skewed toward the apical pole, there was no significant increase in cytokine release on the basolateral pole. Significant basolateral release was observed with STM infection, both relative to control or STY-infected biopsies, demonstrating that the biopsies are viable and capable of responding to pathogen infection. Despite significant cytokine release, no changes in cytokine transcripts were detected in the RNAseq data set (Fig. 2) , suggesting that infection leads to cytokine release from stored intracellular pools and that bacterial exposure likely blocks transcription of new cytokines. The signaling cascades that lead to cytokine transcription are downstream of pattern recognition receptors' activation. Initiation of signaling cascades branching through MAPK and NF-κB were assayed by Western blot analysis of infected biopsies. After 60 min treatment in the microsnapwell chamber, phosphorylated p65, JNK, ERK and p38 was detected in all biopsies. A reduction in the phosphorylation state of p38, p65 and JNK was observed at 120 min post incubation for the control and STY infected samples, but remained phosphorylated in the STM infected biopsies (Fig. 3B) . Analysis of our RNAseq data set predicted p38 (Fig. 3D ) and NF-κB (Fig. 3E) to be important regulators of the gene expression changes observed during infection. The p38 MAPK regulation of numerous Fig. 3D ), with genes downregulated (red) or upregulated (green) after infection, is consistent with STY inhibition of these pathways to disarm the host innate and adaptive immune responses during early infection. These pathways have been identified as targets of S. Typhi in published literature demonstrating NF-κB inhibition in monocytes [74] or MAPK inhibition in the gallbladder epithelium [67] .
STY Targets the Host Cytoskeleton to Infect the Intestinal Epithelium
Bacteria often manipulate the host cytoskeleton during invasion [14, 25, 43, 52, 61, 72] . Within our RNAseq data set, genes involved in cytoskeletal reorganization were downregulated. Formation of cellular protrusions, cytoplasm organization, cytoskeleton reorganization and microtubule dynamics were all identified as pathways predicted to be affected by STY infection (Fig. 4A) . TEM analysis revealed STY invading the intestinal mucosa via the apical surface of the enterocyte (Fig. 4B) . Sites of bacterial invasion are accompanied by microvilli destruction and long protrusions of host cytoskeleton originating from enterocytes. While M cells were observed by TEM (Fig. 1F) , no association of STY with M cells was observed. Furthermore, cytoskeletal projections observed in Fig. 4B were also observed in organoid-derived epithelial monolayers (Fig. 4H) , suggesting that microvilli dissolution and remodeling of the host cytoplasm creates a surface suitable for invasion reproducible in both models.
Subsequently, immunostaining of the cytoskeletal protein actin and the related tight junction protein, zonula occludens-1 (ZO-1), showed actin projections into the lumen beyond the normal cellular structure, while no changes in ZO-1 localization was detected (Fig. 4C) . Despite changes in the cytoskeleton, no changes in paracellular permeability were observed during this early phase of infection as measured by mucosa-to-serosa 4kD FITC-dextran flux (Fig. 4D) and TEER (Fig. 4E) . Additionally, no significant increase in LDH release was detected, indicating that the tissue biopsies were not undergoing cell death in response to bacterial infection (Fig. 4F) . To further explore the role of the cytoskeleton in STY invasion, human organoid-derived epithelial monolayers were treated with medium containing the actin-inhibitor cytochalasin D or the microtubule inhibitor nocodazole prior to infection with STY. Inhibitor treatment prevented STY invasion relative to untreated control monolayers (Fig. 4G) . Lastly, TEM of infected organoid-derived epithelial monolayers recapitulated phenotypes observed in the infected biopsies including cytoskeleton rearrangement, microvilli destruction and vesicle-contained intracellular bacteria (Fig. 4H) . [71] . During early invasion, bacteria co-localized with tubulin ( Fig. 5A ) but they were not present in vesicles labeled with the early endosome protein Rab5. Intracellular bacteria contained within vesicles by TEM (Figs. 1F, 4B ) were also observed, but the vesicle identity remains unclear. It is possible that Rab proteins are not present on these vesicles, as STM effector proteins target Rab proteins to block maturation of the autophagolysosome [13, 28] . Our understanding of STY trafficking inside the epithelial cell is extremely limited. Furthermore, in our transcriptomic data set, we observe downregulation of several genes critical to bacterial clearance (including CYBB and NOS) in the mature phagosome (Fig. 5B) . These data suggest that STY disarms the cellular machinery needed to kill intracellular bacteria by downregulating functional phagosome genes.
Discussion
Enteric pathogens continue to be a significant public health burden in both developed and developing countries [12, 38, 42, 44] . STY remains an elusive vaccine target [24, 41] , which is partly due to critical gaps in knowledge regarding how STY causes disease. Some of these gaps are addressed for the first time in this manuscript.
STY Blocks the Immune Response during Infection
STY produces a polysaccharide capsule known as the Vi antigen, which is thought to protect the bacterial cell from detection by pattern recognition receptors [33, 75, 81, 82] . We conclude that STY further blocks activation of the innate immune system based on depressed or uninduced gene transcription, impaired signal transduction and apical cytokine release observed during human biopsy infection. STY expression of the Vi antigen during human infection (which includes the upregulated genes vexD, vexB, tviE, and tviD) is well-documented [82] , and it masks lipopolysaccharide, peptidoglycan and flagellin from the host pattern recognition receptors. Several additional expressed STY genes that may also block innate immune activation by targeting signal transduction intermediates include the γ-proteobacteria conserved suhB gene [54] , which encodes an inositol monophosphatase and functions in the modulation of inositol signaling [48] . Legionella manipulates inositol signaling to enable creation of the Legionella-containing vacuole for survival [26] . Likewise, STM replicates within the Salmonella-containing vesicle (SCV). Generation of the SCV is dependent on the SPI-1 effectors SopB and SopE/E2 [27] , which modulate inositol signaling and Rab proteins, respectively. The suhB gene overcomes the rate-limiting step in inositol signaling to affect second messenger signaling, autophagy and cell death pathways [26] . Two additional upregulated STY specific-enzymes encode eukaryotic-like serine-threonine kinases (T4519, T4520). In data derived from the infection of immortalized macrophage cell lines, T4519 is required for both intracellular survival and IL-6 and TNF-α production, as well as for NFkB phosphorylation [73] . In line with our data, impaired activation of signal transduction pathways not only prevents gene transcription changes and overall immune response development, but also blocks vesicular trafficking. Salmonella-mediated impaired vesicle maturation prevents lysosomal or autophagolysosomal bacterial killing [28, 57] , thereby allowing bacterial survival and preventing bacterial antigens to stimulate the class I/II major histocompatibility complex (MHC) antigen presentation pathways for the generation of adaptive immune responses. Combined, our data suggest that STY evade innate and adaptive immune responses through multiple and complementary approaches that begin immediately upon invasion and are actively regulated through secreted factors delivered to host enterocytes or the intestinal lumen.
Furthermore, in our model, major MHC-II and reactive oxygen species genes (NADPH-oxidase genes and nitric oxide synthase NOS) are transcriptionally downregulated in response to infection, which may further prevent the host response to STY. Additionally, important immune system genes are downregulated, indicating critical breakpoints in B-cell and T-cell maturation, activation and overall lymphoid cell recruitment to the sites of infection (Supplementary Figs. 3, 4) . Our data, which support clinical observations that STY exposure fails to provoke an immune response, also identifies bacterial genes expressed in the modulation of the host immune response. Further studies and deletion constructs are pivotal to understand the function of these enzymes during STY infection. Our findings provide novel information on mechanisms responsible for the host cell's inability to kill STY. These mechanisms are linked to the inhibition of pathways preventing antigen recognition and, ultimately, the development of an adaptive immune response. This concept is supported by our pathway analysis showing differentially expressed genes associated with the deactivation of pathways involved in the crosstalk between innate and adaptive immune responses (Fig. 5C, Supplementary Fig. 3 ), B-cell receptor signaling ( Supplementary Fig. 4 ) and the maturation of dendritic cells. Ultimately, the downregulation of cell surface genes such as CD22, CD79A and IgG, as well as intracellular signaling genes PI3K and transcription factor PAX5, underscores an inability of the STY infected host cell to activate the adaptive immune system, providing insight into how STY escape clearance by circumventing the host immune system activation.
STY Infects Enterocytes
Historically, enteric pathogens are thought to enter the host by crossing the gastrointestinal epithelium via specialized M-cells [16, 17, 46] . Through TEM analysis, we found numerous epithelial cells in various states of STY invasion. Although research supports a role for M-cells in STM infection [17] , and to a lesser extent in STY infection [24] , we observed that STY infection was predominantly via enterocytes in both tissue explants and gut organoid-derived monolayers, although previous studies have described mechanisms for apical invasion of enterocytes for STM [2] . Common themes observed in infected cells included microvilli destruction and cytoskeletal rearrangement affectingboth actin and tubulin. Furthermore, cytoskeletal projections created a site of invasion that seemed to recruit other STY bacterial cells to enter at the same location. We hypothesize that quorum sensing (QS) facilitates invasion in an energetically favorable manner, by which initial invading bacteria promote microvilli destruction and cytoskeletal rearrangement, and perhaps the release of QS molecules, resulting in cooperative invasion at the same site. STY produces QS molecules homologous to QseBC [53] ; a communication system required for enterohemorrhagic E. coli pathogenesis [58] . Therefore, we hypothesize that the community of invading STY works together to suppress the immune activation in the same cell, enriching its chances of survival by creating invasion "hot spots." The conserved QS genes in the qse and lux/lsr operon are expressed in both our inoculum and invading bacteria, but not differentially expressed during invasion. Curiously, homologs of peptide-based QS genes are differentially expressed during invasion. Peptideinitiated QS is frequently observed in Gram-positive bacteria [65, 77] but only the 'extracellular death factor' peptide QS signaling pathway has been described in Gram-negative E. coli [36, 37, 39] . QS molecules are produced in response to population density and to regulate virulence factors [45, 65] . It is well-documented that QS molecules induce expression of SPI-1 in STM to promote invasion [15, 22, 53, 55] . Importantly, pathogenesis of enterohemorrhagic E. coli depends on host and commensal derived QS molecules to initiate colon invasion, whereas the invasion stimulus for STY, and the potential role for QS, remains an area warranting future investigation.
Host-Specificity of Infection: STM vs. STY
STM causes infection in a genetically susceptible, antibiotictreated mouse [10] . Hallmarks of infection include edema, neutrophil recruitment and bacterial infiltration of the liver, lymph nodes, spleen and cecum [10] . As STM can cause systemic infection, it is used as a model for STY infection in humans. When mice are exposed to STY, the resulting infection is self-limiting within the GI tract and shares very few clinical and pathogenic traits with human disease. Conversely, human infection with STM bacteria results in local gastrointestinal infection that resolves within a few days. Genetically, the two serovars are nearly identical; however STY has gained additional virulence genes [66, 83] (notably, SPI-7) and is thought to have significantly fewer protein-coding genes than STM due to insertion sequences, truncations and mutations [66] . Despite genetic similarities, we observed extensive and divergent phenotypes with human infection by STY as compared to STM. As such, we noticed that the host genes upregulated during STY infection were nearly all divergent between human and mice. For example, the cytokine CCL25 and the mitochondrial enzyme ATP8 are both found in humans but not in mice (Table 4) . Other genes, like the cytoskeletal remodeling gene EPPK1, shares only 75.5% protein identity with its mouse homologue, which allows us to speculate that some of the host specificity of infection is a direct extension of the genes upregulated during infection. Other variables are important here: e.g., human MUC2 shares only 76% identity with its mouse homologue and the MUC2 product functions as a barrier protecting the intestinal epithelium from bacteria. As mice and humans have different pathogen susceptibility and crossing the mucus barrier is a significant challenge to infection, it would be interesting to study if the protein homology differences contribute to infection susceptibility. Further studies are required to evaluate the relative importance of each of the affected genes and virulence factors during the initial stages of infection.
Current vaccine candidates target the following genes in S. Typhi: rpoS, galE, galK, ilvD, vexD, phoP, phoQ, aroC, ssaV, aroD, htrA and tviA. Based on the data presented here, only vexD is upregulated during early infection of human terminal ileum biopsies. Several genes are downregulated (phoPQ, ssaV), while others remain unchanged (galK, ilvD, aroC, aroD, htrA, tviA). These virulence, metabolism and regulatory genes have been considered important targets for initial vaccine candidates [24, 41] by creating strains with limited intracellular replication capacity and attenuated virulence. Based on the results of these studies, we propose targeting additional genes specifically upregulated by STY during early infection, namely enzymes and cytoskeletal rearrangement genes. During infection, invading bacteria are efficiently shutting down the host's ability to recognize and respond to infection by manipulating the epithelial cell and blocking recruitment of immune cells to the site of infection. Deletion of genes utilized during early invasion will likely prevent STY from shutting down the host response, thereby permitting infection recognition and restoring the ability to recruit immune cells to the site of infection. Additionally, genes that target RNA degradation may also hold promise as possible targets for vaccine development. By eliminating the bacterium's ability to suppress host gene expression, perhaps we can restore the development of a strong, protective, adaptive immune response.
An Expanded Model for STY Pathogenesis
As it becomes increasingly clear that our extrapolated data from murine STM studies are insufficient to accurately recapitulate STY pathogenesis in the human host, we have developed a new model that closely resembles the human gut microenvironment to serve as a framework to study STY pathogenesis. Based on our data we propose the following model (Fig. 6 ): STY invades enterocytes of the terminal ileum through cytoskeletal rearrangement by targeting actin and tubulin networks. Upon entry, the bacteria target Rab proteins to conceal the vesicle from the cellular sorting pathways (a fraction of STY might even escape to the cytosol). During this time, the bacteria block host response transcription by targeting signal transduction pathways normally triggered by bacterial antigens. To prevent recruitment of immune cells to the site of infection, the release of cytokines and chemokines is re-directed via the apical surface toward the lumen of the intestine. By crippling the host recognition of invasion (i.e., by reduced or absent triggering of signal transduction and transcriptional downregulation of antibacterial or cytokine genes) STY exploits a "Trojan horse" strategy to prevent detection. STY is protected from host immune defenses and the bacteria move undetected to the basolateral pole and continue systemic dissemination in the host.
Supplementary data to this article can be found online at https://doi. org/10.1016/j.ebiom.2018.04.005.
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